Zoehler, B.; Fracaro, L.; Boldrini-Leite, L.M.; da Silva, J.S.; Travers, P.J.; Brofman, P.R.S.; Bicalho, M.d.G.; Senegaglia, A.C.
HLA-G and CD152 Expression Levels Encourage the Use of Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells as an Alternative for Immunosuppressive Therapy. Cells 2022, 11, 1339.
https://doi.org/10.3390/cells11081339
AMA Style
Zoehler B, Fracaro L, Boldrini-Leite LM, da Silva JS, Travers PJ, Brofman PRS, Bicalho MdG, Senegaglia AC.
HLA-G and CD152 Expression Levels Encourage the Use of Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells as an Alternative for Immunosuppressive Therapy. Cells. 2022; 11(8):1339.
https://doi.org/10.3390/cells11081339
Chicago/Turabian Style
Zoehler, Bernardo, LetÃcia Fracaro, Lidiane Maria Boldrini-Leite, José Samuel da Silva, Paul J. Travers, Paulo Roberto Slud Brofman, Maria da Graça Bicalho, and Alexandra Cristina Senegaglia.
2022. "HLA-G and CD152 Expression Levels Encourage the Use of Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells as an Alternative for Immunosuppressive Therapy" Cells 11, no. 8: 1339.
https://doi.org/10.3390/cells11081339
APA Style
Zoehler, B., Fracaro, L., Boldrini-Leite, L. M., da Silva, J. S., Travers, P. J., Brofman, P. R. S., Bicalho, M. d. G., & Senegaglia, A. C.
(2022). HLA-G and CD152 Expression Levels Encourage the Use of Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells as an Alternative for Immunosuppressive Therapy. Cells, 11(8), 1339.
https://doi.org/10.3390/cells11081339